Mission Statement &
   Academic Aims
   Board of Directors
   Research Profile
  Lipid Signalling
Cardiovascular Signalling
Oncogenic Signalling
Redox Signalling
Biologicals & small molecules in drug research
   Structure and Organisation
   EKF-GK

Get the hottest
news about
FIRST
Open Position
PhD
positions
available
Press Releases
& News
Read more about
FIRST


Call FIRST

+49 (0) 69/798-29801

Mail FIRST



 

Area Oncogenic Signalling

 


Lipid Signalling
Prof. Dr. Dr.
Gerd Geißlinger

Prof. Dr.
Josef Pfeilschifter

Prof. Dr.
Dieter Steinhilber



Cardiovascular Signalling
Prof. Dr.
Ingrid Fleming

Prof. Dr.
Stefanie Dimmeler



Oncogenic Signalling
Prof. Dr.
Rolf Marschalek

Prof. Dr.
Hubert Serve

Prof. Dr.
Simone Fulda



Redox Signalling
Prof. Dr.
B. Brüne

Prof. Dr.
R. Brandes



Biologicals & small molecules in drug research
Prof. Dr. Dr.
Gerd Geisslinger

Prof. Dr.
Josef Pfeilschifter

Prof. Dr.
Heinfried Radeke

 


     GK 1172 Biologicals
 

Coordinators:

Prof. Dr. Rolf Marschalek


Prof. Dr. Hubert Serve

Prof. Dr. Simone Fulda


Targeted cancer therapies interfere with signaling molecules causally involved in carcinogenesis, tumor growth and metastasis. Cancer therapies are aiming to be more effective than current treatments and less harmful to normal cells. Normal cellular homeostasis is maintained by fine-tuned regulatory networks, which are disturbed by alterations in proto-oncogenes and tumor suppressor genes resulting in uncontrolled cell growth.


Participating projects:

Imprint